Malabre Richard C
Insider CIK 2007730 · AKBA SVP, Chief Accounting Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKBA Akebia Therapeutics, Inc. | S Sale | 2026-02-02 | 2026-02-04 | 36,142 | $1.39 | $50.2K | 312,772 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2026-02-02 | 2026-02-04 | 13,382 | $1.39 | $18.6K | 299,390 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2026-01-30 | 2026-02-03 | 119,000 | — | $0 | 119,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2026-01-30 | 2026-02-03 | 79,000 | — | $0 | 348,914 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | M Exercise deriv | 2025-06-09 | 2025-06-11 | 15,000 | — | $0 | 321,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | M Exercise | 2025-06-09 | 2025-06-11 | 15,000 | $1.68 | $25.2K | 281,914 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2025-06-09 | 2025-06-11 | 15,000 | $4.01 | $60.1K | 266,914 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2025-06-04 | 2025-06-05 | 13,334 | $3.53 | $47.1K | 266,914 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2025-02-03 | 2025-02-04 | 30,202 | $2.10 | $63.4K | 280,248 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2025-01-31 | 2025-02-04 | 128,000 | — | $0 | 128,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2025-01-31 | 2025-02-04 | 85,000 | — | $0 | 310,450 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2024-01-31 | 2024-02-02 | 336,000 | — | $0 | 336,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2024-01-31 | 2024-02-02 | 223,950 | — | $0 | 223,950 | SEC↗ |